Literature DB >> 10603381

Two distinct antigenic types of the polysaccharide chains of Helicobacter pylori lipopolysaccharides characterized by reactivity with sera from humans with natural infection.

S I Yokota1, K I Amano, Y Shibata, M Nakajima, M Suzuki, S Hayashi, N Fujii, T Yokochi.   

Abstract

We have purified lipopolysaccharides (LPS) from 10 Helicobacter pylori clinical isolates which were selected on the basis of chemotype and antigenic variation. Data from immunoblotting of the purified LPS with sera from humans with H. pylori infection and from absorption of the sera with LPS indicated the presence of two distinct epitopes, termed the highly antigenic and the weakly antigenic epitopes, on the polysaccharide chains. Among 68 H. pylori clinical isolates, all smooth strains possessed either epitope; the epitopes were each carried by about 50% of the smooth strains. Thus, H. pylori strains can be classified into three types on the basis of their antigenicity in humans: those with smooth LPS carrying the highly antigenic epitope, those with smooth LPS carrying the weakly antigenic epitope, and those with rough LPS. Sera from humans with H. pylori infection could be grouped into three categories: those containing immunoglobulin G (IgG) antibodies against the highly antigenic epitope, those containing IgG against the weakly antigenic epitope, and those containing both specific IgGs; these groups made up about 50%, less than 10%, and about 40%, respectively, of all infected sera tested. In other words, IgG against the highly antigenic epitope were detected in more than 90% of H. pylori-infected individuals with high titers. IgG against the weakly antigenic epitope were detected in about 50% of the sera tested; however, the antibody titers were low. The two human epitopes existed independently from the mimic structures of Lewis antigens, which are known to be an important epitope of H. pylori LPS. No significant relationship between the reactivities toward purified LPS of human sera and a panel of anti-Lewis antigen antibodies was found. Moreover, the reactivities of the anti-Lewis antigen antibodies, but not human sera, were sensitive to particular alpha-L-fucosidases. The human epitopes appeared to be located on O-polysaccharide chains containing endo-beta-galactosidase-sensitive galactose residues as the backbone. Data from chemical analyses indicated that all LPS commonly contained galactose, glucosamine, glucose, and fucose (except one rough strain) as probable polysaccharide components, together with typical components of inner core and lipid A. We were not able to distinguish between the differences of antigenicity in humans by on the basis of the chemical composition of the LPS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10603381      PMCID: PMC97114          DOI: 10.1128/IAI.68.1.151-159.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

2.  Purification of -L-fucosidase from the liver of a marine gastropod, Turbo cornutus, and its action on blood group substances.

Authors:  Y Iijima; T Muramatsu; F Egami
Journal:  Arch Biochem Biophys       Date:  1971-07       Impact factor: 4.013

3.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

4.  Phenotypic diversity in Lewis expression of Helicobacter pylori isolates from the same host.

Authors:  H P Wirth; M Yang; R M Peek; J Höök-Nikanne; M Fried; M J Blaser
Journal:  J Lab Clin Med       Date:  1999-05

5.  Chemical characterization of lipopolysaccharides from Proteus strains used in Weil-Felix test.

Authors:  S Mizushiri; K Amano; S Fuji; K Fukushi; M Watanabe
Journal:  Microbiol Immunol       Date:  1990       Impact factor: 1.955

6.  Low biological activity of Helicobacter pylori lipopolysaccharide.

Authors:  A Muotiala; I M Helander; L Pyhälä; T U Kosunen; A P Moran
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Chemical properties of lipopolysaccharides from spotted fever group rickettsiae and their common antigenicity with lipopolysaccharides from Proteus species.

Authors:  K Amano; M Fujita; T Suto
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Structure and biological relationships of Coxiella burnetii lipopolysaccharides.

Authors:  K Amano; J C Williams; S R Missler; V N Reinhold
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

9.  Antigenicity of Helicobacter pylori lipopolysaccharides.

Authors:  S D Mills; L A Kurjanczyk; J L Penner
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

10.  Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.

Authors:  P J Hitchcock; T M Brown
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

View more
  8 in total

1.  Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity.

Authors:  M A Heneghan; C F McCarthy; D Janulaityte; A P Moran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Helicobacter pylori specific immune response induced by conservative flagellin linear B-cell epitope.

Authors:  Wan-Sheng Ji; Jia-Lu Hu; Kai-Chun Wu; Jun-Wen Qiu; Zhe-Yi Han; Jie Ding; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

3.  Implication of antigenic conversion of Helicobacter pylori lipopolysaccharides that involve interaction with surfactant protein D.

Authors:  Shin-ichi Yokota; Ken-ichi Amano; Chiaki Nishitani; Shigeru Ariki; Yoshio Kuroki; Nobuhiro Fujii
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

4.  Phenotypic variation of Helicobacter pylori isolates from geographically distinct regions detected by lectin typing.

Authors:  Sean O Hynes; Nathalie Broutet; Torkel Wadström; Marika Mikelsaar; Paul W O'Toole; John Telford; Lars Engstrand; Shigeru Kamiya; Andreas F Mentis; Anthony P Moran
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

5.  Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway.

Authors:  Shin-Ichi Yokota; Tamaki Okabayashi; Michael Rehli; Nobuhiro Fujii; Ken-Ichi Amano
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

6.  Helicobacter pylori with a truncated lipopolysaccharide O chain fails to induce gastritis in SCID mice injected with splenocytes from wild-type C57BL/6J mice.

Authors:  K A Eaton; S M Logan; P E Baker; R A Peterson; M A Monteiro; E Altman
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

7.  Comparison of the Serological Reactivity of Lipopolysaccharides from Japanese and Western Strains of Helicobacter pylori to Sera from H. pylori-Positive Humans.

Authors:  Ken-Ichi Amano; Shin-Ichi Yokota; Mario A Monteiro
Journal:  ISRN Microbiol       Date:  2012-07-26

8.  Unique repertoire of anti-carbohydrate antibodies in individual human serum.

Authors:  Ralph N D Luetscher; Tanya R McKitrick; Chao Gao; Akul Y Mehta; Alyssa M McQuillan; Robert Kardish; Kayluz Frias Boligan; Xuezheng Song; Lenette Lu; Jamie Heimburg-Molinaro; Stephan von Gunten; Galit Alter; Richard D Cummings
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.